Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A new report just published on line in the Journal of Urology has shown that — at least in the state of North Carolina — distance from the nearest urologist affects prostate cancer risk category at diagnosis and may disproportionately impact black as opposed to white patients.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: category, distance, race, risk, urologist | 1 Comment »
According to new data from a study at the University of Chicago, African-American males scheduled for a prostate biopsy are at greater risk for a positive diagnosis of cancer than white males and they also significantly underestimate their probability of a positive biopsy result.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: belief, biopsy, ethnicity, outcome, race, risk | Leave a Comment »
A new retrospective analysis of data from > 2,300 patients suggests that African-American men are a greater risk for biochemical disease recurrence after brachytherapy alone than Hispanics or Caucasian men, but
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: African American, brachytherapy, mortality, outcome, race, recurrence | 1 Comment »
A new study just published in Urology seems to confirm facts that have previously been identified in earlier studies of how men elect to get treated for localized prostate cancer in parts of the USA with a high proportion of African American residents and relatively low income levels.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: communication, decision-making, environment, race, rural, Treatment | Leave a Comment »
One of the other major initiatives that have been funded over several years by the Department of Defense’s Prostate Cancer Research Program is the North Carolina-Louisiana Prostate Cancer Project (often just known as PCaP).
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, disparities, ethnicity, race, risk | Leave a Comment »
Barocas and Penson have offered a helpful new review of racial variation in the patterns and the quality of care offered to prostate cancer patients in the USA. The entire paper is available on line through the UroToday web site.
Filed under: Living with Prostate Cancer, Management | Tagged: care, pattern, quality, race, variation | Leave a Comment »
Unsurprisingly, the longer a man older than 65 years goes between PSA tests, the greater is the likelihood that he will be diagnosed with clinically significant prostate cancer that has escaped from the prostate (especially if he has never had a PSA test until he became Medicare eligiible).
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: age, Diagnosis, PSA, race, risk, stage | Leave a Comment »
The news reports today cover studies on: Initial PSA levels and risk for prostate cancer in black and in white Americans 3 T MR imaging, MRI-guided biopsies, and identification of sites of local recurrence after first-line EBRT pT0 disease in men with biopsy-detected prostate cancer Outcomes of immediate surgery compared to deferred treatment
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: defferred, immediate, MRI-guided biopsy, PSA level, pT0 disease, race, risk, surgery, Treatment | 7 Comments »
In this weekend’s prostate cancer news reports, we have addressed recent publications on: A SNP that may be specifically linked to risk for prostate cancer in African Americans The need for extended biopsies in men with larger prostates who are considering focal treatment for prostate cancer A possible association between diabetes, race, obesity, and risk [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: African American, age, biopsy, brachytherapy, diabetes, focal, hormone therapy, mortality, neoadjuvant, obesity, race, single nucleotide polymorphism, SNP, Treatment | Leave a Comment »
The differences in risk for and mortality from prostate cancer across racial and ethnic lines have been well documented.However, there has been continuing controversy over the degree to which socioeconomic status (SES) may be able to account for these differences.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ethnicity, mortality, race, risk | Leave a Comment »
Today’s news reports address: Prevalence of comorbidities in black and white patients PSA screening and the criteria for biopsy Screening and management of men > 65 years of age Genitourinary toxicity of intensity modulated radiation therapy (IMRT)
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: comorbidity, genitourinary toxicity, IMRT, race, risk, screening | Leave a Comment »
There has been a positive plethora of news reports over the past 24 hours, starting with the very important issuance of the AUA/ASCO guideline on the potential use of 5-ARIs for the prevention of prostate cancer. This will be just the first of at least three groups of news reports today! This report deals with: [...]
Filed under: Diagnosis, Drugs in development, Risk | Tagged: ethnicity, IGF-I, insulin-like growth factor I, phenoxodiol, PSA, race, sarcosine research test, variants | Leave a Comment »
The issue of whether race and socioeconomic status impact prostate cancer treatment outcomes is fraught with all sorts of pitfalls: emotional, statistical, political, medical, societal, you name it.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ethnicity, outcome, race, risk, socioeconomic status | Leave a Comment »
There are multiple news reports available today, including coverage of the following: Vegetable consumption and prostate cancer risk Anti-hypertensive medications and prostate cancer risk Prostate cancer incidence among South Indian and Pakistani immigrants to the United States Bladder neck contracture and type of surgery Cytotoxic and targeted chemotherapies in the managment of prostate cancer The [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: anti-hypertensives, bladder neck contracture, chemotherapy, choice, cytotoxic, detection, immigrants, Indian, Pakistani, race, risk, targeted, USA, vegetables | Leave a Comment »
There are several interesting news items today, as follows: Ethnic variation in the performance of PSA and PSA density as markers for risk of prostate cancer Potential underuse of active surveillance in eligible patients Application of active surveillance in a 40-patient case series The potential to eliminate the need for a urethral (Foley) catheter post-surgery [...]
Filed under: Diagnosis, Management, Treatment, Uncategorized | Tagged: active, androgen, cancer, catheter, CTC, density, deprivation, ethnicity, news, prostate, PSA, race, surveillance, update | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site